Faraday Pharmaceuticals is a clinical-stage biopharmaceutical company founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center. The company pioneered the use of elemental reducing agents to protect against muscle loss in cardiac and critical care settings. As of 2025, the company has ceased operations and is winding down.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account